KR101472594B1 - 체성에서 유래하는 복수의 세포종을 포함하는 원시적인 기관 모양을 이룰 수 있는 세포 덩어리 - Google Patents
체성에서 유래하는 복수의 세포종을 포함하는 원시적인 기관 모양을 이룰 수 있는 세포 덩어리 Download PDFInfo
- Publication number
- KR101472594B1 KR101472594B1 KR1020087028837A KR20087028837A KR101472594B1 KR 101472594 B1 KR101472594 B1 KR 101472594B1 KR 1020087028837 A KR1020087028837 A KR 1020087028837A KR 20087028837 A KR20087028837 A KR 20087028837A KR 101472594 B1 KR101472594 B1 KR 101472594B1
- Authority
- KR
- South Korea
- Prior art keywords
- cell
- cells
- cell mass
- wnt signal
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000004027 cell Anatomy 0.000 title claims abstract description 240
- 210000005056 cell body Anatomy 0.000 title 1
- 210000000056 organ Anatomy 0.000 claims abstract description 28
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 11
- 238000004519 manufacturing process Methods 0.000 claims abstract description 6
- 230000002500 effect on skin Effects 0.000 claims description 41
- 238000000034 method Methods 0.000 claims description 41
- 230000014509 gene expression Effects 0.000 claims description 29
- 108090000623 proteins and genes Proteins 0.000 claims description 28
- 210000002510 keratinocyte Anatomy 0.000 claims description 27
- 210000003780 hair follicle Anatomy 0.000 claims description 25
- 239000012190 activator Substances 0.000 claims description 19
- 239000003814 drug Substances 0.000 claims description 14
- 230000003779 hair growth Effects 0.000 claims description 14
- 102000001267 GSK3 Human genes 0.000 claims description 13
- 108010014905 Glycogen Synthase Kinase 3 Proteins 0.000 claims description 13
- 238000012835 hanging drop method Methods 0.000 claims description 11
- 238000004113 cell culture Methods 0.000 claims description 10
- 229940079593 drug Drugs 0.000 claims description 9
- 230000015572 biosynthetic process Effects 0.000 claims description 8
- 230000000694 effects Effects 0.000 claims description 8
- 230000001939 inductive effect Effects 0.000 claims description 7
- 102100024505 Bone morphogenetic protein 4 Human genes 0.000 claims description 6
- 101000762379 Homo sapiens Bone morphogenetic protein 4 Proteins 0.000 claims description 6
- 101001044927 Homo sapiens Insulin-like growth factor-binding protein 3 Proteins 0.000 claims description 6
- 102100038895 Myc proto-oncogene protein Human genes 0.000 claims description 6
- 101710135898 Myc proto-oncogene protein Proteins 0.000 claims description 6
- 101710150448 Transcriptional regulator Myc Proteins 0.000 claims description 6
- 230000002401 inhibitory effect Effects 0.000 claims description 6
- 102100022708 Insulin-like growth factor-binding protein 3 Human genes 0.000 claims description 5
- 238000012136 culture method Methods 0.000 claims description 3
- 238000012216 screening Methods 0.000 claims description 3
- 230000001747 exhibiting effect Effects 0.000 claims description 2
- 210000001082 somatic cell Anatomy 0.000 abstract description 41
- 239000002609 medium Substances 0.000 abstract description 30
- 238000012258 culturing Methods 0.000 abstract description 28
- 230000003213 activating effect Effects 0.000 abstract description 8
- 239000001963 growth medium Substances 0.000 abstract description 7
- 239000006143 cell culture medium Substances 0.000 abstract 1
- 102000013814 Wnt Human genes 0.000 description 30
- 108050003627 Wnt Proteins 0.000 description 30
- 108020004414 DNA Proteins 0.000 description 25
- 210000002919 epithelial cell Anatomy 0.000 description 19
- 210000000130 stem cell Anatomy 0.000 description 18
- 210000004209 hair Anatomy 0.000 description 17
- 230000000692 anti-sense effect Effects 0.000 description 16
- 210000001519 tissue Anatomy 0.000 description 16
- 238000006243 chemical reaction Methods 0.000 description 11
- 238000010240 RT-PCR analysis Methods 0.000 description 10
- 230000003993 interaction Effects 0.000 description 10
- 108060000903 Beta-catenin Proteins 0.000 description 9
- 102000015735 Beta-catenin Human genes 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 9
- 102000004142 Trypsin Human genes 0.000 description 8
- 108090000631 Trypsin Proteins 0.000 description 8
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 7
- 229930105110 Cyclosporin A Natural products 0.000 description 7
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 7
- 108010036949 Cyclosporine Proteins 0.000 description 7
- 102000004495 STAT3 Transcription Factor Human genes 0.000 description 7
- 108010017324 STAT3 Transcription Factor Proteins 0.000 description 7
- 108700013515 Wnt3A Proteins 0.000 description 7
- 229960001265 ciclosporin Drugs 0.000 description 7
- 230000004069 differentiation Effects 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 210000003491 skin Anatomy 0.000 description 7
- 238000010186 staining Methods 0.000 description 7
- 239000012588 trypsin Substances 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 102000044880 Wnt3A Human genes 0.000 description 6
- 229940098773 bovine serum albumin Drugs 0.000 description 6
- 238000012744 immunostaining Methods 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 238000003757 reverse transcription PCR Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 6
- 101000994365 Homo sapiens Integrin alpha-6 Proteins 0.000 description 5
- 102100032816 Integrin alpha-6 Human genes 0.000 description 5
- 102000011782 Keratins Human genes 0.000 description 5
- 108010076876 Keratins Proteins 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 239000012298 atmosphere Substances 0.000 description 5
- 239000006285 cell suspension Substances 0.000 description 5
- 210000005175 epidermal keratinocyte Anatomy 0.000 description 5
- 210000002615 epidermis Anatomy 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 230000003325 follicular Effects 0.000 description 5
- 239000003550 marker Substances 0.000 description 5
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 230000001172 regenerating effect Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 108090000031 Hedgehog Proteins Proteins 0.000 description 4
- 102000003693 Hedgehog Proteins Human genes 0.000 description 4
- 102100040445 Keratin, type I cytoskeletal 14 Human genes 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 4
- 230000004663 cell proliferation Effects 0.000 description 4
- 239000002299 complementary DNA Substances 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 238000002054 transplantation Methods 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 3
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 3
- 101710183391 Keratin, type I cytoskeletal 14 Proteins 0.000 description 3
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 3
- 241000124008 Mammalia Species 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 102000040945 Transcription factor Human genes 0.000 description 3
- 108091023040 Transcription factor Proteins 0.000 description 3
- 102100035071 Vimentin Human genes 0.000 description 3
- 108010065472 Vimentin Proteins 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 230000024245 cell differentiation Effects 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 238000004043 dyeing Methods 0.000 description 3
- 210000001339 epidermal cell Anatomy 0.000 description 3
- ZNNLBTZKUZBEKO-UHFFFAOYSA-N glyburide Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZNNLBTZKUZBEKO-UHFFFAOYSA-N 0.000 description 3
- 238000003317 immunochromatography Methods 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 230000005305 organ development Effects 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 229960005322 streptomycin Drugs 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 210000005048 vimentin Anatomy 0.000 description 3
- CRDNMYFJWFXOCH-YPKPFQOOSA-N (3z)-3-(3-oxo-1h-indol-2-ylidene)-1h-indol-2-one Chemical compound N/1C2=CC=CC=C2C(=O)C\1=C1/C2=CC=CC=C2NC1=O CRDNMYFJWFXOCH-YPKPFQOOSA-N 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- 102000029816 Collagenase Human genes 0.000 description 2
- 108060005980 Collagenase Proteins 0.000 description 2
- 241000255925 Diptera Species 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 229930182816 L-glutamine Natural products 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- 238000011579 SCID mouse model Methods 0.000 description 2
- CGNLCCVKSWNSDG-UHFFFAOYSA-N SYBR Green I Chemical compound CN(C)CCCN(CCC)C1=CC(C=C2N(C3=CC=CC=C3S2)C)=C2C=CC=CC2=[N+]1C1=CC=CC=C1 CGNLCCVKSWNSDG-UHFFFAOYSA-N 0.000 description 2
- 239000008049 TAE buffer Substances 0.000 description 2
- HGEVZDLYZYVYHD-UHFFFAOYSA-N acetic acid;2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid Chemical compound CC(O)=O.OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O HGEVZDLYZYVYHD-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000012574 advanced DMEM Substances 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 210000000845 cartilage Anatomy 0.000 description 2
- 239000012930 cell culture fluid Substances 0.000 description 2
- 229950001002 cianidanol Drugs 0.000 description 2
- 229960002424 collagenase Drugs 0.000 description 2
- 210000004087 cornea Anatomy 0.000 description 2
- 239000012531 culture fluid Substances 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 210000001671 embryonic stem cell Anatomy 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 210000002782 epithelial mesenchymal cell Anatomy 0.000 description 2
- 238000007667 floating Methods 0.000 description 2
- 210000000185 follicular epithelial cell Anatomy 0.000 description 2
- 210000003953 foreskin Anatomy 0.000 description 2
- 239000012737 fresh medium Substances 0.000 description 2
- 229960002743 glutamine Drugs 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000023643 hair follicle morphogenesis Effects 0.000 description 2
- 238000003018 immunoassay Methods 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000008611 intercellular interaction Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000011580 nude mouse model Methods 0.000 description 2
- 210000004415 olfactory epithelial cell Anatomy 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 238000002271 resection Methods 0.000 description 2
- 230000011664 signaling Effects 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 230000000392 somatic effect Effects 0.000 description 2
- 230000023895 stem cell maintenance Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- UHHSUGRHGZBBCL-UHFFFAOYSA-N 2-chloro-1-(3,3-dibromo-2h-thiophen-5-yl)ethanone Chemical compound ClCC(=O)C1=CC(Br)(Br)CS1 UHHSUGRHGZBBCL-UHFFFAOYSA-N 0.000 description 1
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
- 125000004217 4-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C([H])([H])* 0.000 description 1
- 102100022900 Actin, cytoplasmic 1 Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 239000012103 Alexa Fluor 488 Substances 0.000 description 1
- 229930183010 Amphotericin Natural products 0.000 description 1
- QGGFZZLFKABGNL-UHFFFAOYSA-N Amphotericin A Natural products OC1C(N)C(O)C(C)OC1OC1C=CC=CC=CC=CCCC=CC=CC(C)C(O)C(C)C(C)OC(=O)CC(O)CC(O)CCC(O)C(O)CC(O)CC(O)(CC(O)C2C(O)=O)OC2C1 QGGFZZLFKABGNL-UHFFFAOYSA-N 0.000 description 1
- APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 1
- 229920001342 Bakelite® Polymers 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- CRDNMYFJWFXOCH-BUHFOSPRSA-N Couroupitine B Natural products N\1C2=CC=CC=C2C(=O)C/1=C1/C2=CC=CC=C2NC1=O CRDNMYFJWFXOCH-BUHFOSPRSA-N 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 108010066321 Keratin-14 Proteins 0.000 description 1
- 241000699660 Mus musculus Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 241000282579 Pan Species 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 101150099493 STAT3 gene Proteins 0.000 description 1
- 241000555745 Sciuridae Species 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- JDSJDASOXWCHPN-UHFFFAOYSA-N TDZD-8 Chemical compound O=C1N(C)SC(=O)N1CC1=CC=CC=C1 JDSJDASOXWCHPN-UHFFFAOYSA-N 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 230000031712 Wnt receptor signaling pathway, planar cell polarity pathway Effects 0.000 description 1
- HUDSYNWJCPDHLL-CJLVFECKSA-N [(E)-[2-(6-bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino] acetate Chemical compound CC(=O)O\N=C1\C(=Nc2ccccc12)c1c(O)[nH]c2cc(Br)ccc12 HUDSYNWJCPDHLL-CJLVFECKSA-N 0.000 description 1
- 150000003793 acetoxime derivatives Chemical class 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 229940009444 amphotericin Drugs 0.000 description 1
- 229960003942 amphotericin b Drugs 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000004637 bakelite Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 210000000270 basal cell Anatomy 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000009087 cell motility Effects 0.000 description 1
- 230000008614 cellular interaction Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 108010007093 dispase Proteins 0.000 description 1
- 210000003317 double-positive, alpha-beta immature T lymphocyte Anatomy 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000008472 epithelial growth Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000012757 fluorescence staining Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 210000002768 hair cell Anatomy 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 238000011532 immunohistochemical staining Methods 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 229940125721 immunosuppressive agent Drugs 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000035990 intercellular signaling Effects 0.000 description 1
- 230000016507 interphase Effects 0.000 description 1
- 230000031146 intracellular signal transduction Effects 0.000 description 1
- CRDNMYFJWFXOCH-UHFFFAOYSA-N isoindigotin Natural products N1C2=CC=CC=C2C(=O)C1=C1C2=CC=CC=C2NC1=O CRDNMYFJWFXOCH-UHFFFAOYSA-N 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000004324 lymphatic system Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000037306 mature skin Effects 0.000 description 1
- 125000001434 methanylylidene group Chemical group [H]C#[*] 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 210000000956 olfactory bulb Anatomy 0.000 description 1
- 210000001706 olfactory mucosa Anatomy 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 229940056360 penicillin g Drugs 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 238000013376 serial cultivation Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 125000000437 thiazol-2-yl group Chemical group [H]C1=C([H])N=C(*)S1 0.000 description 1
- 230000009772 tissue formation Effects 0.000 description 1
- 230000030968 tissue homeostasis Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000011830 transgenic mouse model Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- -1 urea compound Chemical class 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
- C12N5/0627—Hair cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
- C12N5/0629—Keratinocytes; Whole skin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0666—Mesenchymal stem cells from hair follicles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/415—Wnt; Frizzeled
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Dermatology (AREA)
- Developmental Biology & Embryology (AREA)
- Rheumatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006176763 | 2006-06-27 | ||
| JPJP-P-2006-176763 | 2006-06-27 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20090021340A KR20090021340A (ko) | 2009-03-03 |
| KR101472594B1 true KR101472594B1 (ko) | 2014-12-15 |
Family
ID=38845692
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020087028837A Active KR101472594B1 (ko) | 2006-06-27 | 2008-11-25 | 체성에서 유래하는 복수의 세포종을 포함하는 원시적인 기관 모양을 이룰 수 있는 세포 덩어리 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US8563309B2 (enExample) |
| EP (2) | EP2034011B1 (enExample) |
| JP (3) | JP2013059337A (enExample) |
| KR (1) | KR101472594B1 (enExample) |
| CN (1) | CN101479376A (enExample) |
| ES (2) | ES2641528T3 (enExample) |
| WO (1) | WO2008001938A1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018124450A1 (ko) * | 2016-12-26 | 2018-07-05 | 동국대학교 산학협력단 | 특정 전자기파 처리를 통한 효율적 3d 중뇌 유사 오가노이드 제조 방법 |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009086000A2 (en) * | 2007-12-19 | 2009-07-09 | Aderans Research Institute, Inc. | Biomarkers for trichogenicity |
| CN101658518B (zh) * | 2009-08-19 | 2011-06-08 | 新疆奥斯曼生物化妆品有限公司 | 靛玉红用作制备育毛发的药物中的用途 |
| GB201112922D0 (en) * | 2011-07-27 | 2011-09-14 | Univ Durham | Micro-organ |
| AU2014259787B2 (en) * | 2013-05-03 | 2018-03-08 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Skin substitutes and methods for hair follicle neogenesis |
| WO2015155738A2 (en) | 2014-04-09 | 2015-10-15 | Christopher Rudd | Use of gsk-3 inhibitors or activators which modulate pd-1 or t-bet expression to modulate t cell immunity |
| JP6218238B2 (ja) * | 2014-07-10 | 2017-10-25 | 国立大学法人大阪大学 | 人工皮膚及びその製造方法 |
| CN120924475A (zh) | 2014-09-18 | 2025-11-11 | 北卡罗来纳大学 | 哺乳动物肺球体和肺球体细胞及其应用 |
| JP6425319B2 (ja) | 2015-10-30 | 2018-11-28 | 国立大学法人横浜国立大学 | 複数の再生毛包原基の製造方法、毛包組織含有シートの製造方法、毛包組織含有シート及び培養基板の使用 |
| JP7150604B2 (ja) * | 2016-01-28 | 2022-10-11 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | 無血清合成のためのｗｎｔ組成物及び方法 |
| FR3061207B1 (fr) * | 2016-12-23 | 2023-03-10 | Oreal | Utilisation des cellules germinales pour la preparation d’un microfollicule pileux |
| CN110392686A (zh) | 2016-12-30 | 2019-10-29 | 频率治疗公司 | 1h-吡咯-2,5-二酮化合物以及使用它们来诱导干/祖支持细胞自我更新的方法 |
| JP2020516282A (ja) * | 2017-04-11 | 2020-06-11 | フリークエンシー セラピューティクス インコーポレイテッド | 毛包幹細胞増殖のための方法 |
| WO2019092667A1 (en) * | 2017-11-10 | 2019-05-16 | Vitroscreen S.R.L. | Method for preparing three-dimensional scaffold-free microtissues for use in the preclinical screening of active substances |
| CN108486035B (zh) * | 2018-03-26 | 2021-11-26 | 西北大学 | 一种三维类器官的液滴培养方法 |
| JP7142840B2 (ja) | 2018-05-16 | 2022-09-28 | 国立大学法人横浜国立大学 | 細胞含有ハイドロゲル体及びその製造方法 |
| JP7246595B2 (ja) * | 2018-11-08 | 2023-03-28 | 国立大学法人横浜国立大学 | 毛包原基、毛包原基の製造方法、及び毛包原基に含まれる細胞の活性化方法 |
| JP7702229B2 (ja) * | 2018-11-19 | 2025-07-03 | 株式会社 資生堂 | 毛包を有するヒト皮膚組織を再構成するための組成物、ヒト皮膚組織モデル動物およびその製造方法 |
| KR102636511B1 (ko) * | 2020-03-20 | 2024-02-14 | 주식회사 에이엔케이 | 기판 상에 형성된 모낭 세포 스페로이드 및 이의 제조방법 |
| KR102636512B1 (ko) * | 2020-03-20 | 2024-02-14 | 주식회사 에이엔케이 | 모유두 세포의 반복 시딩 및 배양을 통한 모유두 스페로이드의 제조방법 |
| WO2022039165A1 (ja) | 2020-08-18 | 2022-02-24 | 東ソー株式会社 | 多能性幹細胞の外胚葉、中胚葉及び内胚葉系細胞への分化誘導方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4813734B2 (ja) * | 2000-03-31 | 2011-11-09 | ザ ジェネラル ホスピタル コーポレイション | 毛の成長を調節する方法 |
| WO2003082234A1 (fr) * | 2002-03-28 | 2003-10-09 | Shiseido Co., Ltd. | Derives de phenylacetonitrile, tonique capillaire et preparations externes pour la peau contenant ces derives |
| JP2004248632A (ja) * | 2003-02-21 | 2004-09-09 | Osaka Industrial Promotion Organization | 男性型脱毛症治療薬のスクリーニング方法、男性型脱毛症治療薬の製造方法および男性型脱毛症治療薬。 |
| JP2005237273A (ja) * | 2004-02-26 | 2005-09-08 | Shiseido Co Ltd | 育毛剤の評価方法 |
| AU2004317828B2 (en) * | 2004-03-31 | 2010-06-24 | Reliance Life Sciences Pvt Ltd | Tissue-like organization of cells and macroscopic tissue-like constructs, generated by macromass culture of cells, and the method of macromass culture |
| JP4565112B2 (ja) * | 2004-09-15 | 2010-10-20 | 独立行政法人産業技術総合研究所 | 毛髪成長促進剤、発毛促進剤及び脱毛症治療剤 |
| JP2005021171A (ja) * | 2004-10-04 | 2005-01-27 | Shiseido Co Ltd | ヒト毛芽の活性化作用の検出方法 |
-
2007
- 2007-06-27 CN CNA2007800242047A patent/CN101479376A/zh active Pending
- 2007-06-27 US US12/306,649 patent/US8563309B2/en not_active Expired - Fee Related
- 2007-06-27 EP EP07768103.9A patent/EP2034011B1/en not_active Not-in-force
- 2007-06-27 ES ES12155498.4T patent/ES2641528T3/es active Active
- 2007-06-27 WO PCT/JP2007/063333 patent/WO2008001938A1/ja not_active Ceased
- 2007-06-27 ES ES07768103T patent/ES2419232T3/es active Active
- 2007-06-27 EP EP12155498.4A patent/EP2455111B1/en not_active Not-in-force
-
2008
- 2008-11-25 KR KR1020087028837A patent/KR101472594B1/ko active Active
-
2012
- 2012-11-12 JP JP2012248660A patent/JP2013059337A/ja active Pending
-
2013
- 2013-02-04 JP JP2013019652A patent/JP2013078344A/ja active Pending
- 2013-09-18 US US14/030,449 patent/US20140106432A1/en not_active Abandoned
-
2015
- 2015-06-30 JP JP2015131234A patent/JP5976172B2/ja active Active
- 2015-07-01 US US14/788,925 patent/US10344266B2/en active Active
Non-Patent Citations (1)
| Title |
|---|
| Havlickova, B. et al., British Journal of Dermatology, 2004: 151:753-765 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018124450A1 (ko) * | 2016-12-26 | 2018-07-05 | 동국대학교 산학협력단 | 특정 전자기파 처리를 통한 효율적 3d 중뇌 유사 오가노이드 제조 방법 |
| US11980642B2 (en) | 2016-12-26 | 2024-05-14 | Dongguk University Industry—Academic Cooperation Foundation | Method for efficiently producing 3D midbrain-like organoid through specific electromagnetic wave processing |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2455111B1 (en) | 2017-08-16 |
| US20090280469A1 (en) | 2009-11-12 |
| US20160160185A1 (en) | 2016-06-09 |
| US10344266B2 (en) | 2019-07-09 |
| CN101479376A (zh) | 2009-07-08 |
| EP2034011A4 (en) | 2009-11-25 |
| EP2455111A2 (en) | 2012-05-23 |
| JP2015165823A (ja) | 2015-09-24 |
| US20140106432A1 (en) | 2014-04-17 |
| ES2641528T3 (es) | 2017-11-10 |
| JP5976172B2 (ja) | 2016-08-23 |
| WO2008001938A1 (en) | 2008-01-03 |
| JP2013059337A (ja) | 2013-04-04 |
| ES2419232T3 (es) | 2013-08-20 |
| EP2455111A3 (en) | 2012-06-13 |
| EP2034011A1 (en) | 2009-03-11 |
| EP2034011B1 (en) | 2013-05-22 |
| US8563309B2 (en) | 2013-10-22 |
| KR20090021340A (ko) | 2009-03-03 |
| JP2013078344A (ja) | 2013-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101472594B1 (ko) | 체성에서 유래하는 복수의 세포종을 포함하는 원시적인 기관 모양을 이룰 수 있는 세포 덩어리 | |
| US20110165130A1 (en) | Methods for Preparing Human Skin Substitutes from Human Pluripotent Stem Cells | |
| CN106661547B (zh) | 调控毛发生长的方法和组合物 | |
| US10398735B2 (en) | Compositions and methods for producing reconstituted skin | |
| JP5258213B2 (ja) | 体性に由来する複数の細胞種からなる原始的な器官様をなし得る細胞塊 | |
| US20220002678A1 (en) | Composition for reconstituting human skin tissue having hair follicles, human skin tissue model animal, and production method thereof | |
| TW201504435A (zh) | 毛囊形成用組合物之品質管理方法 | |
| JP7444367B2 (ja) | 増幅毛包間葉系細胞の製造方法及びその使用 | |
| Yoo et al. | Effect of mesenchymal cells on human hair growth and death | |
| KR100939360B1 (ko) | 여성의 소음순 유래 성체세포로부터 리프로그래밍의 과정을통해 인슐린 분비 세포를 제조하는 방법 및 상기 분화된인슐린 분비 세포의 세포 치료제로서의 용도 | |
| Yoo et al. | Hair multiplication with dermal papilla like tissue containing human dermal papilla cells | |
| KR20210100206A (ko) | 미세 모낭의 제조에 있어서의 배 세포의 용도 | |
| KR20090126226A (ko) | 여성의 소음순 유래 성체세포로부터 리프로그래밍의 과정을 통해 인슐린 분비 세포를 제조하는 방법 및 상기 분화된 인슐린 분비 세포의 세포 치료제로서의 용도 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20081125 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20120615 Comment text: Request for Examination of Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20131219 Patent event code: PE09021S01D |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20140917 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20141208 Patent event code: PR07011E01D |
|
| PR1002 | Payment of registration fee |
Payment date: 20141208 End annual number: 3 Start annual number: 1 |
|
| PG1601 | Publication of registration | ||
| FPAY | Annual fee payment |
Payment date: 20171107 Year of fee payment: 4 |
|
| PR1001 | Payment of annual fee |
Payment date: 20171107 Start annual number: 4 End annual number: 4 |
|
| FPAY | Annual fee payment |
Payment date: 20181031 Year of fee payment: 5 |
|
| PR1001 | Payment of annual fee |
Payment date: 20181031 Start annual number: 5 End annual number: 5 |
|
| PR1001 | Payment of annual fee |
Payment date: 20201118 Start annual number: 7 End annual number: 7 |
|
| PR1001 | Payment of annual fee |
Payment date: 20211122 Start annual number: 8 End annual number: 8 |
|
| PR1001 | Payment of annual fee |
Payment date: 20231128 Start annual number: 10 End annual number: 10 |